MannKind Corp MNKD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:58 PM EDT
4.17quote price arrow up+0.09 (+2.33%)
Volume
1,193,205
52 week range
3.17 - 5.75
Loading...
  • Open4.06
  • Day High4.19
  • Day Low4.02
  • Prev Close4.08
  • 52 Week High5.75
  • 52 Week High Date08/09/23
  • 52 Week Low3.17
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap1.13B
  • Shares Out270.68M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change14.7

KEY STATS

  • Open4.06
  • Day High4.19
  • Day Low4.02
  • Prev Close4.08
  • 52 Week High5.75
  • 52 Week High Date08/09/23
  • 52 Week Low3.17
  • 52 Week Low Date02/05/24
  • Market Cap1.13B
  • Shares Out270.68M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change14.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-89.96
  • Fwd P/E (NTM)31.63
  • EBITDA (TTM)15.254M
  • ROE (TTM)-
  • Revenue (TTM)198.962M
  • Gross Margin (TTM)68.45%
  • Net Margin (TTM)-6.00%
  • Debt To Equity (MRQ)-210.68%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MannKind Corp

 

Profile

MORE
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. Its products include Afrezza (insulin human) Inhalation Powder...
James Shannon M.D.
Independent Chairman of the Board
Michael Castagna Pharm.D.
Chief Executive Officer, Director
Lauren Sabella
Chief Operating Officer, Executive Vice President
Steven Binder
Chief Financial Officer
David Thomson J.D., Ph.D.
Executive Vice President, General Counsel, Secretary
Address
1 Casper Street
Danbury, CT
06810
United States

Top Peers

SYMBOLLASTCHG%CHG
MIRM
Mirum Pharmaceuticals Inc
23.79+0.21+0.91%
DCPH
Deciphera Pharmaceuticals Inc
14.65+0.42+2.99%
XNCR
Xencor Inc
18.35-0.60-3.17%
PACB
Pacific Biosciences of California Inc
1.54+0.08+5.82%
EOLS
Evolus Inc
11.51-0.05-0.43%